No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs188893937 |
chr6:49377052-49377053 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs9473547 |
chr6:49377094-49377095 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
3 |
rs192101186 |
chr6:49377192-49377193 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs554891046 |
chr6:49377205-49377206 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs374623906 |
chr6:49377213-49377214 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs34972586 |
chr6:49377240-49377241 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs573204577 |
chr6:49377303-49377304 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs540388510 |
chr6:49377312-49377313 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs183577185 |
chr6:49377339-49377340 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs532612545 |
chr6:49377395-49377396 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs201498778 |
chr6:49377404-49377405 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs543459805 |
chr6:49377434-49377435 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs201323900 |
chr6:49377452-49377453 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs188512367 |
chr6:49377505-49377506 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs562887052 |
chr6:49377527-49377528 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs530161185 |
chr6:49377587-49377588 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs67620692 |
chr6:49377654-49377655 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs67497669 |
chr6:49377655-49377656 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs141829858 |
chr6:49377665-49377666 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs398065786 |
chr6:49377666-49377667 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs201092395 |
chr6:49377669-49377670 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs534438570 |
chr6:49377687-49377688 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs145909467 |
chr6:49377741-49377742 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs541027910 |
chr6:49377768-49377769 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs566729982 |
chr6:49377772-49377773 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs527597671 |
chr6:49377795-49377796 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs554636230 |
chr6:49377798-49377799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs2501980 |
chr6:49377819-49377820 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs12525035 |
chr6:49377987-49377988 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs543641486 |
chr6:49378126-49378127 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs192213327 |
chr6:49378130-49378131 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs537929685 |
chr6:49378136-49378137 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs184048588 |
chr6:49378137-49378138 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs567715764 |
chr6:49378142-49378143 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs138824581 |
chr6:49378144-49378145 |
Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|